At a glance
ClinicalIndex Comparison RecordN/ACompleted· 12 enrolled
Drug / intervention
Honda Stride Assist Device ON +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Development of Walk Assist Device to Improve Community Ambulation
In Brief
A clinical study evaluating Honda Stride Assist Device ON and No Device Worn for Stroke. Completed, enrolled 12 participants across 1 site.
Detailed Summary
The goal of this research study was to examine the immediate effects of a prototype wearable robotic stride management assist device (SMA) designed by Honda R\&D® on clinical walking performance, walking energetics, gait kinematics and corticospinal excitability in individuals with stroke.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsStroke
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
20102011201220132014201520162017201820192020202120222023202420252026
Enrollment StartJan 2010
First PostedJul 2017
Primary CompletionMay 2018
TodayJul 2026
First PostedJul 19, 2017
Enrollment StartJan 1, 2010
Primary CompletionMay 1, 2018
TodayJul 2, 2026
Enrollment to primary: 8.3 yearsPosted 9.0 years ago
Interventions
Honda Stride Assist Device ONdevice
Subjects performed assessments of walking and motor performance while wearing the Honda Stride Assist Device.
No Device Wornother
Subjects performed assessments of walking and motor performance without wearing the Honda Assist Device.